(FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | -162.04%-5.19M | -1.98M |
Other cash income from operating activities | -162.04%-5.19M | ---1.98M |
Cash paid | ||
Operating cash flow | -162.04%-5.19M | ---1.98M |
Investing cash flow | ||
Cash flow from continuing investing activities | -204.38%-5.95M | -1.96M |
Capital expenditure reported | -191.34%-5.37M | ---1.84M |
Net PPE purchase and sale | -416.34%-588.87K | ---114.05K |
Interest received (cash flow from investment activities) | 244.53%10.05K | --2.92K |
Cash from discontinued investing activities | ||
Investing cash flow | -204.38%-5.95M | ---1.96M |
Financing cash flow | ||
Cash flow from continuing financing activities | -60.35%4.16M | 10.5M |
Net issuance payments of debt | 76.17%-240K | ---1.01M |
Net common stock issuance | -61.56%4.47M | --11.64M |
Net other financing activities | 45.64%-69.23K | ---127.36K |
Cash from discontinued financing activities | ||
Financing cash flow | -60.35%4.16M | --10.5M |
Net cash flow | ||
Beginning cash position | 291.16%8.82M | --2.26M |
Current changes in cash | -206.26%-6.98M | --6.57M |
End cash Position | -79.09%1.84M | --8.82M |
Free cash from | -183.12%-11.15M | ---3.94M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data